Culver City, California
United States
87
2026-05-07
67
2026-03-17
These are the the leading inventors for applications assigned to NANTOMICS, LLC:
NANTOMICS, LLC based in Culver City, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#2 | 2026-03-05Machine Methods To Determine Neoepitope Payload Toxicity
#3 | 2025-11-13REAL-TIME WHOLE SLIDE PATHOLOGY IMAGE CELL COUNTING
#4 | 2025-06-05Cancer Neoepitopes
#5 | 2025-04-10WEAKLY SUPERVISED LEARNING WITH WHOLE SLIDE IMAGES
#6 | 2025-02-20CLASSIFICATION BASED ON CHARACTERIZATION ANALYSIS METHODS AND SYSTEMS
#7 | 2025-01-16 ✅ Patent 12,580,910 granted on 2026-03-17SYNTHETIC GENOMIC VARIANT-BASED SECURE TRANSACTION DEVICES, SYSTEMS AND METHODS
#8 | 2024-10-24Method Of Validating The Triggering Of An Immune Response To A Neoepitope Of A Tumor With T-Cells
#9 | 2024-10-17DIFFERENCE-BASED GENOMIC IDENTITY SCORES
#10 | 2024-09-26Viral Neoepitopes and Uses Thereof
#11 | 2024-08-15DIGITAL HISTOPATHOLOGY AND MICRODISSECTION
#12 | 2024-07-11 ✅ Patent 12,406,366 granted on 2025-09-02REAL-TIME WHOLE SLIDE PATHOLOGY IMAGE CELL COUNTING
#13 | 2024-07-11 ✅ Patent 12,205,033 granted on 2025-01-21Weakly supervised learning with whole slide images
#14 | 2024-05-30 ✅ Patent 12,614,612 granted on 2026-04-28HLA Tissue Matching And Methods Therefor
#15 | 2024-05-23 ✅ Patent 12,224,066 granted on 2025-02-11Deep learning models for region of interest determination
#16 | 2024-05-09Systems And Methods For Genetic Analysis Of Metastases
#17 | 2024-01-18Cancer Score for Assessment and Response Prediction from Biological Fluids
#18 | 2023-12-28Cancer Score for Assessment and Response Prediction from Biological Fluids
#19 | 2023-11-30 ✅ Patent 12,195,808 granted on 2025-01-14Dynamic changes in circulating free RNA of neural tumors
#20 | 2023-11-23 ✅ Patent 12,412,639 granted on 2025-09-09IMMUNE GENE EXPRESSION SIGNATURE IN TREG ENRICHED TUMOR SAMPLES
#21 | 2023-09-28Systems, Compositions, And Methods For Discovery Of MSI And Neoepitopes That Predict Sensitivity To Checkpoint Inhibitors
#22 | 2023-08-31METHODS AND SYSTEMS FOR IMPROVED MAJOR HISTOCOMPATIBILITY COMPLEX (MHC)-PEPTIDE BINDING PREDICTION OF NEOEPITOPES USING A RECURRENT NEURAL NETWORK ENCODER AND ATTENTION WEIGHTING
#23 | 2023-08-24 ✅ Patent 12,518,214 granted on 2026-01-06Distributed Machine Learning Systems, Apparatus, And Methods
#24 | 2023-08-17 ✅ Patent 12,052,240 granted on 2024-07-30Synthetic genomic variant-based secure transaction devices, systems and methods
#25 | 2023-08-17 ✅ Patent 12,170,142 granted on 2024-12-17Classification based on characterization analysis methods and systems
#26 | 2023-07-06 ✅ Patent 12,404,490 granted on 2025-09-02Cancer Neoepitopes
#27 | 2023-04-27 ✅ Patent 12,002,262 granted on 2024-06-04Digital histopathology and microdissection
#28 | 2023-02-02 ✅ Patent 12,224,064 granted on 2025-02-11Deep learning models for tumor evaluation
#29 | 2022-12-22 ✅ Patent 11,694,122 granted on 2023-07-04Distributed machine learning systems, apparatus, and methods
#30 | 2022-12-22 ✅ Patent 12,545,928 granted on 2026-02-10Machine Methods To Determine Neoepitope Payload Toxicity
#31 | 2022-11-24 ✅ Patent 11,948,687 granted on 2024-04-02Deep learning models for region-of-interest determination
#32 | 2022-11-24 ✅ Patent 11,954,856 granted on 2024-04-09Real-time whole slide pathology image cell counting
#33 | 2022-09-15Genomic-driven targeted therapies
#34 | 2022-07-14 ✅ Patent 11,785,004 granted on 2023-10-10Synthetic genomic variant-based secure transaction devices, systems and methods
#35 | 2022-06-09 ✅ Patent 11,954,596 granted on 2024-04-09Weakly supervised learning with whole slide images
#36 | 2022-03-24 ✅ Patent 11,676,707 granted on 2023-06-13Classification based on characterization analysis methods and systems
#37 | 2022-01-27 ✅ Patent 11,981,893 granted on 2024-05-14DNA stabilization of RNA
#38 | 2021-12-23 ✅ Patent 12,487,240 granted on 2025-12-02TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#39 | 2021-11-25 ✅ Patent 11,821,043 granted on 2023-11-21Dynamic changes in circulating free RNA of neural tumors
#40 | 2021-10-07 ✅ Patent 12,094,574 granted on 2024-09-17Difference-based genomic identity scores
#41 | 2021-07-01 ✅ Patent 11,557,375 granted on 2023-01-17Methods and systems for improved major histocompatibility complex (MHC)-peptide binding prediction of neoepitopes using a recurrent neural network encoder and attention weighting
#42 | 2021-04-22 ✅ Patent 12,053,512 granted on 2024-08-06Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells
#43 | 2020-12-17 ✅ Patent 11,443,426 granted on 2022-09-13Real-time whole slide pathology image cell counting
#44 | 2020-12-10 ✅ Patent 11,756,651 granted on 2023-09-12Method of treating a tumor in a patient based on an immune gene expression
#45 | 2020-10-22 ✅ Patent 11,810,672 granted on 2023-11-07Cancer score for assessment and response prediction from biological fluids
#46 | 2020-07-16 ✅ Patent 11,908,588 granted on 2024-02-20Systems and methods for genetic analysis of metastases
#47 | 2020-06-04 ✅ Patent 11,168,323 granted on 2021-11-09DNA stabilization of RNA
#48 | 2020-05-21 ✅ Patent 11,195,062 granted on 2021-12-07Classification based on characterization analysis methods and systems
#49 | 2020-05-14 ✅ Patent 11,682,195 granted on 2023-06-20Digital histopathology and microdissection
#50 | 2020-04-16 ✅ Patent 11,717,564 granted on 2023-08-08Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
#51 | 2020-03-26 ✅ Patent 11,504,420 granted on 2022-11-22AGGF1 immunogenic compositions
#52 | 2020-03-12 ✅ Patent 11,276,479 granted on 2022-03-15Tumor antigenicity processing and presentation
#53 | 2020-03-05 ✅ Patent 10,736,884 granted on 2020-08-11Compositions and methods of Rit1 inhibition
#54 | 2019-12-26 ✅ Patent 10,748,056 granted on 2020-08-18Methods and systems for predicting DNA accessibility in the pan-cancer genome
#55 | 2019-10-10 ✅ Patent 12,205,678 granted on 2025-01-21Genome explorer system to process and present nucleotide variations in genome sequence data
#56 | 2019-09-26Quantifying KRAS for Optimal Cancer Therapy
#57 | 2019-09-19 ✅ Patent 12,080,382 granted on 2024-09-03Viral neoepitopes and uses thereof
#58 | 2019-08-29 ✅ Patent 10,725,045 granted on 2020-07-28Quantifying MGMT protein for optimal cancer therapy of glioblastoma
#59 | 2019-08-29 ✅ Patent 10,722,531 granted on 2020-07-28OPRT expression and cancer treatment outcome
#60 | 2019-08-01 ✅ Patent 11,875,877 granted on 2024-01-16Immunotherapy markers and uses therefor
#61 | 2019-07-25PROTEOMICS ANALYSIS AND DISCOVERY THROUGH DNA AND RNA SEQUENCING, SYSTEMS AND METHODS
#62 | 2019-07-18 ✅ Patent 10,722,509 granted on 2020-07-28Predicting optimal chemotherapy for CRC
#63 | 2019-06-13 ✅ Patent 10,620,184 granted on 2020-04-14SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein
#64 | 2019-05-16CHECKPOINT FAILURE AND METHODS THEREFOR
#65 | 2019-03-14 ✅ Patent 10,769,788 granted on 2020-09-08Few-shot learning based image recognition of whole slide image at tissue level
#66 | 2019-01-31 ✅ Patent 11,361,841 granted on 2022-06-14High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
#67 | 2019-01-17 ✅ Patent 11,785,002 granted on 2023-10-10Synthetic genomic variant-based secure transaction devices, systems and methods
#68 | 2019-01-17Integrated Analysis To Determine Prognosis After Treatment For Primary Breast Cancer
#69 | 2018-08-23 ✅ Patent 11,393,557 granted on 2022-07-19Systems and methods for high-accuracy variant calling
#70 | 2018-07-05 ✅ Patent 10,525,040 granted on 2020-01-07Compositions and methods of Rit1 inhibition
#71 | 2018-05-24 ✅ Patent 10,467,523 granted on 2019-11-05Methods and systems for predicting DNA accessibility in the pan-cancer genome
#72 | 2018-05-24 ✅ Patent 11,421,016 granted on 2022-08-23Cancer neoepitopes
#73 | 2018-04-26 ✅ Patent 10,607,343 granted on 2020-03-31Digital histopathology and microdissection
#74 | 2018-03-29 ✅ Patent 10,487,078 granted on 2019-11-26Compositions and methods of targeting mutant K-RAS
#75 | 2018-01-18 ✅ Patent 11,461,690 granted on 2022-10-04Distributed machine learning systems, apparatus, and methods
#76 | 2018-01-04 ✅ Patent 11,101,038 granted on 2021-08-24Systems and methods for response prediction to chemotherapy in high grade bladder cancer
#77 | 2018-01-04 ✅ Patent 10,984,890 granted on 2021-04-20Synthetic WGS bioinformatics validation
#78 | 2017-11-02 ✅ Patent 11,154,597 granted on 2021-10-26Sequence arrangements and sequences for neoepitope presentation
#79 | 2017-02-02 ✅ Patent 10,339,274 granted on 2019-07-02Viral neoepitopes and uses thereof
#80 | 2017-02-02 ✅ Patent 11,626,187 granted on 2023-04-11Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors
#81 | 2017-02-02 ✅ Patent 11,623,001 granted on 2023-04-11Compositions and methods for viral cancer neoepitopes
#82 | 2017-02-02 ✅ Patent 10,532,089 granted on 2020-01-14Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
#83 | 2016-07-28 ✅ Patent 10,323,285 granted on 2019-06-18Proteomics analysis and discovery through DNA and RNA sequencing, systems and methods
#84 | 2016-03-10 ✅ Patent 10,050,959 granted on 2018-08-14Synthetic genomic variant-based secure transaction devices, systems and methods
#85 | 2016-01-28 ✅ Patent 10,614,910 granted on 2020-04-07Systems and methods for comprehensive analysis of molecular profiles across multiple tumor and germline exomes
#86 | 2015-01-01 ✅ Patent 11,011,273 granted on 2021-05-18Pathway analysis for identification of diagnostic tests
#87 | 2014-04-24 ✅ Patent 10,347,361 granted on 2019-07-09Genome explorer system to process and present nucleotide variations in genome sequence data
Also check out NANTOMICS, LLC's (Culver City, United States) applicant profile with 79 patent applications submitted.
130816 ⎘